Process Development for a Key Synthetic Intermediate of LY2140023, a Clinical Candidate for the Treatment of Schizophrenia by Waser, Mario, Moher, Eric D., Borders, Sandy S. K., Hansen, Marvin M., Hoard, David W., Laurila, Michael E., LeTourneau, Michael E., Miller, Richard D., Phillips, Michael L., Sullivan, Kevin A., Ward, Jeffrey A., Xie, Chaoyu, Bye, Cheryl A., Leitner, Tanja, Herzog-Krimbacher, Brigitte, Kordian, Marcus, Müllner, Martin

Get full text